Form 4: J&J HR Chief's PSU Award Certified

Sentiment:

Insider Transaction Report


Johnson & Johnson's EVP, Chief HR Officer, Kristen Mulholland, had 3,602 Performance Share Units certified, reflecting achievement of performance conditions.

Summary

  • Kristen Mulholland, EVP, Chief HR Officer of Johnson & Johnson (JNJ), reported the certification of 3,602 Performance Share Units (PSUs).
  • These PSUs were originally granted on February 13, 2023, under the Issuer's Long-Term Incentive Plan.
  • The certification on February 9, 2026, reflects the achievement of performance conditions set forth in the award agreement.
  • The PSUs convert into shares of Common Stock upon vesting, with 3,602 shares underlying the units.
  • The derivative security price is $0, as it represents an award.
  • Following this reported transaction, Mulholland beneficially owns 3,602 derivative securities (PSUs).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it confirms the achievement of performance targets for executive compensation, which can be interpreted as a positive indicator of company performance against internal metrics.

Positives

  • Certification of 3,602 Performance Share Units indicates that performance conditions for the award, granted on February 13, 2023, were met. This suggests the company achieved specific targets.

Future Outlook

The 3,602 Performance Share Units are scheduled to vest on February 13, 2026, at which point they will convert into shares of Johnson & Johnson Common Stock.

Industry Context

StockSavvy.ai notes that the use of Performance Share Units (PSUs) as a component of executive compensation is a common practice across large, publicly traded companies, particularly in the healthcare and pharmaceutical sectors. This structure aligns executive incentives with long-term company performance and shareholder value creation.

Comparison to Industry Standards

  • The structure of this long-term incentive award, involving PSUs tied to performance conditions and a future vesting date, is consistent with executive compensation practices observed at peer companies such as Pfizer (PFE), Merck (MRK), and Abbott Laboratories (ABT). These companies frequently utilize similar equity-based awards to incentivize executives and retain talent, linking compensation directly to the achievement of strategic and financial goals.

Stakeholder Impact

  • Shareholders: Potential minor dilution upon vesting of PSUs into common stock, but the underlying performance achievement is generally positive.
  • Executive (Kristen Mulholland): Direct financial benefit from the vesting of equity awards, aligning her interests with long-term company performance.

Next Steps

  • The 3,602 Performance Share Units are expected to vest on February 13, 2026, converting into shares of Johnson & Johnson Common Stock.

Key Dates

DateDescription
02/13/2023Original grant date of Performance Share Units (PSUs) under the Issuer's Long-Term Incentive Plan.
02/09/2026Date performance conditions for the PSUs were certified, leading to the reported transaction.
02/11/2026Date the Form 4 was signed by the attorney-in-fact for Kristen Mulholland.
02/13/2026Date the Performance Share Units become exercisable (vesting date), converting into shares of Common Stock.

Keywords

Johnson & Johnson, JNJ, Form 4, insider transaction, executive compensation, Performance Share Units, PSU, Kristen Mulholland, long-term incentive plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.